Hemex Health Stock

Develops malaria and sickle cell diagnostic devices.

About Hemex Health Stock

They seek out and work with brilliant inventors to deliver revolutionary solutions to global health problems. Our innovative products are designed to help millions of people across all markets, especially in underserved areas.

Funding History

December 2016	$1.5M
June 2017	$3.0M
August 2017	$25K
November 2017	$600K
December 2017	$1.7M

Management

CIO

Peter Galen

CEO

Patti White

Vice President Engineering

Daren Bledsoe

Other Companies

Learn More

Arvinas

Arvinas is a pharmaceutical company focused on protein degradation approaches to develop novel drugs to treat cancer and other diseases.

$112MTotal Funding

Learn More

Nerium Biotechnology

Nerium Biotechnology engages in the development of oleander-based products for the treatment of proliferative diseases and viral infections.

$289KTotal Funding

Learn More

Veritas Genetics

Vertias Genetics' purpose is to make actionable genetic information accessible to all.

$542MTotal Funding

Learn More

Vital

Modern cloud-based Emergency Department SaaS

$6.2MTotal Funding

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Hemex Health or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 80K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Why EquityZen?

EquityZen helps investors to access private companies and their employees to sell shares.

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2020 EquityZen Inc. All rights reserved.